On September 12, 2017, Inotek Pharmaceuticals agreed to acquire Rocket Pharmaceuticals, Ltd., a privately held bio-pharmaceutical company in a tax-deferred acquisition. The Form 8-K for Inotek (NASDAQ ticker ITEK, cik 0001281895) describes the transaction and was filed with the SEC on August 13, 2012. You can access the Form 8-K at the SEC’s Investor website: (https://www.sec.gov/Archives/edgar/data/1281895/000119312517283239/d421363d8k.htm).
Read “Item 1.01, Entry into a Material Definitive Agreement” and determine which form of merger was used to affect the acquisition.